KOD — Kodiak Sciences Inc. catalysts
Next verified catalyst
2027-02-01 — A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participant · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-02 (month) in 4mo
ESTIMATED |
READOUT
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in P
Phase 3 · Macular Edema Secondary to Inflammation |
KOD Kodiak Sciences Inc. | KSI-101 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-03
Sponsor-projected date — can change
|